NextCure, Inc.
NXTC
$12.04
-$0.52-4.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.87% | 0.57% | 22.30% | 11.27% | 10.74% |
| Total Depreciation and Amortization | -17.28% | -18.40% | -22.34% | -22.23% | -22.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.15% | -45.54% | -40.21% | -6.91% | -16.31% |
| Change in Net Operating Assets | -15.10% | -111.18% | -47.99% | 333.61% | 206.40% |
| Cash from Operations | -9.97% | -18.11% | 18.91% | 22.97% | 13.16% |
| Capital Expenditure | 106.53% | 78.41% | 28.24% | 42.20% | 68.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.07% | -19.63% | 13.41% | 39.13% | 28.56% |
| Cash from Investing | -49.51% | -18.80% | 14.06% | 40.83% | 32.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,054.49% | 1,054.49% | -8.39% | -7.14% | 23.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,054.49% | 1,054.49% | -8.39% | -7.14% | 23.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -349.06% | -1,262.68% | 129.86% | 208.09% | 170.96% |